Literature DB >> 32818658

A novel homozygous KY variant causing a complex neurological disorder.

Beenish Arif1, Arisha Rasheed1, Kishore R Kumar2, Amara Fatima1, Ghazanfar Abbas1, Elizabeth Wohler3, Nara Sobriera3, Katja Lohmann4, Sadaf Naz5.   

Abstract

Mutations in the gene kyphoscoliosis peptidase (KY) are known to cause myofibrillar myopathy-7 and hereditary spastic paraplegia. We investigated the genetic cause of a complex neurological phenotype in a consanguineous Pakistani family with four affected members, manifesting lower limb spasticity and weakness, toe walking, pes equinovarus, and a speech disorder. Genome-wide linkage analysis with microsatellite markers delineated chromosome 3q22.2-q24 harboring the disease gene. Whole exome sequencing was performed for two subjects, identifying a homozygous 14-bp frameshift deletion NM_178554.6:c.842_855del; p(Val281GlyfsTer18) in KY. The variant segregated with the phenotype and was absent from public databases and 100 ethnically matched controls. We confirm a novel homozygous KY variant causing a complex neurological phenotype in this family. A review of previously reported KY variants suggests that variants in this gene can cause a spectrum of neurological phenotypes.
Copyright © 2020 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Hereditary spastic paraplegia; KY; Kyphoscoliosis peptidase; Pesequinovarus; Speech disorder

Mesh:

Substances:

Year:  2020        PMID: 32818658      PMCID: PMC7554104          DOI: 10.1016/j.ejmg.2020.104031

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  12 in total

1.  Kyphoscoliosis peptidase (KY) mutation causes a novel congenital myopathy with core targetoid defects.

Authors:  Rachel Straussberg; Gudrun Schottmann; Menachem Sadeh; Esther Gill; Franziska Seifert; Ayelet Halevy; Kaiyal Qassem; John Rendu; Peter F M van der Ven; Werner Stenzel; Markus Schuelke
Journal:  Acta Neuropathol       Date:  2016-08-02       Impact factor: 17.088

2.  A new early-onset neuromuscular disorder associated with kyphoscoliosis peptidase (KY) deficiency.

Authors:  Carola Hedberg-Oldfors; Niklas Darin; Mia Olsson Engman; Zacharias Orfanos; Christer Thomsen; Peter F M van der Ven; Anders Oldfors
Journal:  Eur J Hum Genet       Date:  2016-08-03       Impact factor: 4.246

3.  Progressive hereditary spastic paraplegia caused by a homozygous KY mutation.

Authors:  Yuval Yogev; Yonatan Perez; Iris Noyman; Anwar Abu Madegem; Hagit Flusser; Zamir Shorer; Eugene Cohen; Leonid Kachko; Analia Michaelovsky; Ruth Birk; Arie Koifman; Max Drabkin; Ohad Wormser; Daniel Halperin; Rotem Kadir; Ohad S Birk
Journal:  Eur J Hum Genet       Date:  2017-05-10       Impact factor: 4.246

4.  The kyphoscoliosis (ky) mouse is deficient in hypertrophic responses and is caused by a mutation in a novel muscle-specific protein.

Authors:  G Blanco; G R Coulton; A Biggin; C Grainge; J Moss; M Barrett; A Berquin; G Maréchal; M Skynner; P van Mier; A Nikitopoulou; M Kraus; C P Ponting; R M Mason; S D Brown
Journal:  Hum Mol Genet       Date:  2001-01-01       Impact factor: 6.150

5.  A novel neuromuscular form of glycogen storage disease type IV with arthrogryposis, spinal stiffness and rare polyglucosan bodies in muscle.

Authors:  Edoardo Malfatti; Christine Barnerias; Carola Hedberg-Oldfors; Cyril Gitiaux; Audrey Benezit; Anders Oldfors; Robert-Yves Carlier; Susana Quijano-Roy; Norma B Romero
Journal:  Neuromuscul Disord       Date:  2016-07-25       Impact factor: 4.296

6.  Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics.

Authors:  Linn Fagerberg; Björn M Hallström; Per Oksvold; Caroline Kampf; Dijana Djureinovic; Jacob Odeberg; Masato Habuka; Simin Tahmasebpoor; Angelika Danielsson; Karolina Edlund; Anna Asplund; Evelina Sjöstedt; Emma Lundberg; Cristina Al-Khalili Szigyarto; Marie Skogs; Jenny Ottosson Takanen; Holger Berling; Hanna Tegel; Jan Mulder; Peter Nilsson; Jochen M Schwenk; Cecilia Lindskog; Frida Danielsson; Adil Mardinoglu; Asa Sivertsson; Kalle von Feilitzen; Mattias Forsberg; Martin Zwahlen; IngMarie Olsson; Sanjay Navani; Mikael Huss; Jens Nielsen; Fredrik Ponten; Mathias Uhlén
Journal:  Mol Cell Proteomics       Date:  2013-12-05       Impact factor: 5.911

Review 7.  Myofibrillar myopathy in the genomic context.

Authors:  Jakub Piotr Fichna; Aleksandra Maruszak; Cezary Żekanowski
Journal:  J Appl Genet       Date:  2018-09-10       Impact factor: 3.240

8.  A global reference for human genetic variation.

Authors:  Adam Auton; Lisa D Brooks; Richard M Durbin; Erik P Garrison; Hyun Min Kang; Jan O Korbel; Jonathan L Marchini; Shane McCarthy; Gil A McVean; Gonçalo R Abecasis
Journal:  Nature       Date:  2015-10-01       Impact factor: 49.962

9.  The ExAC browser: displaying reference data information from over 60 000 exomes.

Authors:  Konrad J Karczewski; Ben Weisburd; Brett Thomas; Matthew Solomonson; Douglas M Ruderfer; David Kavanagh; Tymor Hamamsy; Monkol Lek; Kaitlin E Samocha; Beryl B Cummings; Daniel Birnbaum; Mark J Daly; Daniel G MacArthur
Journal:  Nucleic Acids Res       Date:  2016-11-28       Impact factor: 16.971

10.  Identification of a novel nonsense mutation in kyphoscoliosis peptidase gene in an Iranian patient with myofibrillar myopathy.

Authors:  Reza Ebrahimzadeh-Vesal; Atieh Teymoori; Ali Mohammad Dourandish; Mohsen Azimi-Nezhad
Journal:  Genes Dis       Date:  2018-10-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.